In vitro, the combination of CDK1 knockdown with Chk1 inhibition reversed the Chk1 effect in HNSCC, and similar effects were observed using the CDK4/6 inhibitor Palbociclib. The gene discussed is CHEK1; the disease is head and neck squamous cell carcinoma.